Invention Grant
- Patent Title: Method for the in vitro prediction of the probability of a patient developing severe dengue, based on a blood sample
-
Application No.: US15852528Application Date: 2017-12-22
-
Publication No.: US10823732B2Publication Date: 2020-11-03
- Inventor: Frederic Bedin
- Applicant: BIOMERIEUX
- Applicant Address: FR Marcy l'Etoile
- Assignee: BIOMERIEUX
- Current Assignee: BIOMERIEUX
- Current Assignee Address: FR Marcy l'Etoile
- Agency: Oliff PLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@2ef05d49
- Main IPC: G01N33/82
- IPC: G01N33/82 ; G01N33/569 ; G01N33/68
Abstract:
A kit for in vitro prediction of severe dengue includes a binding partner specific for leucine-rich alpha-2 glycoprotein, a binding partner specific for vitamin D-binding protein, and a binding partner specific for ferritin. The kit may further include at least one binding partner specific for a dengue virus protein wherein the dengue virus protein is the NS1 protein, the envelope protein, or the prM protein.
Public/Granted literature
Information query
IPC分类:
